Indinavir urinary stones as origin of upper urinary tract obstruction

Urologia Internationalis

Volumn 59, Issue 4, 1997, Pages 257-259

  John, H ^a   Muller N J ^a   Opravil, M ^a   Hauri, D ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

AIDS; Calculi; Crixivan ; Indinavir; Urinary; Urinary tract obstruction

Indexed keywords

ANTIVIRUS AGENT; INDINAVIR; LAMIVUDINE; PROTEINASE INHIBITOR; ZIDOVUDINE;

AGED; ARTICLE; CASE REPORT; FLUID INTAKE; HEMATURIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDRONEPHROSIS; MALE; PRIORITY JOURNAL; UROLITHIASIS;

EID: 1842293382     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000283075     Document Type: Article

References (7)

1. Gulick R, Mcllors J, Uavlur D, et al: Potent and sustained antiretroviral activity of indinavir (IDV) in combination with zidovudine (ADV) and lantivudine (3TC) (abstract 162). 3rd Conf on Retroviruses and Opportunistic Infections, Washington, 1996.
2. 3 (abstract 67). Int Workshop on HIV Drug Resistance, Treatment-Strategies and Eradication. St. Petersburg, Fla. June 1997.
3. Stein DS, Fish DG, Bilello JA, Preston SI., Martineau GL, Drusano GL: A 24-weck open-label phase I/II evaluation of the HIV protcase inhibitor MK.-639 (Indinavir). AIDS 1996; 10: 485-492.
4. Arzneimittclkompendium der Schweiz. Basel, Dokumed, 1997, pp 468-470.
5. Chen IW, Vastag KJ, Lin JH: High-performance liquid chromatographic determination of a potent and selective HIV protease inhibitor (L-735.524) in rat dog and monkey plasma. J Chromatogr 1995,672:111-117.
6. Daudon M, Estepa L, Viard JP, Joly D, Jungers P: Urinary stones in HIV-l-positivc patients treated with indinavir (letter). Lancet 1997; 349:1294-1295.
7. Tashioa KT, Horowitz JD, Rosen S: Indinavir nephropathy (letter). N Engl J Med 1997:336: 138-139.